These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22748651)

  • 1. Potential role for STAT3 inhibitors in glioblastoma.
    Jackson C; Ruzevick J; Amin AG; Lim M
    Neurosurg Clin N Am; 2012 Jul; 23(3):379-89. PubMed ID: 22748651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Stat3 in glioblastoma multiforme.
    Luwor RB; Stylli SS; Kaye AH
    J Clin Neurosci; 2013 Jul; 20(7):907-11. PubMed ID: 23688441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 as a Therapeutic Target for Glioblastoma.
    Liu Y; Li C; Lin J
    Anticancer Agents Med Chem; 2010 Sep; 10(7):512-9. PubMed ID: 20879983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
    Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
    Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
    Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
    J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
    Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
    Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy.
    Germain D; Frank DA
    Clin Cancer Res; 2007 Oct; 13(19):5665-9. PubMed ID: 17908954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.
    Hussain SF; Kong LY; Jordan J; Conrad C; Madden T; Fokt I; Priebe W; Heimberger AB
    Cancer Res; 2007 Oct; 67(20):9630-6. PubMed ID: 17942891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of STAT3 activation in modulating the immune microenvironment of GBM.
    See AP; Han JE; Phallen J; Binder Z; Gallia G; Pan F; Jinasena D; Jackson C; Belcaid Z; Jeong SJ; Gottschalk C; Zeng J; Ruzevick J; Nicholas S; Kim Y; Albesiano E; Pardoll DM; Lim M
    J Neurooncol; 2012 Dec; 110(3):359-68. PubMed ID: 23096132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
    Jagannathan J; Prevedello DM; Dumont AS; Laws ER
    Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age.
    Gray GK; McFarland BC; Nozell SE; Benveniste EN
    Expert Rev Neurother; 2014 Nov; 14(11):1293-306. PubMed ID: 25262780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblastoma.
    Kang SH; Yu MO; Park KJ; Chi SG; Park DH; Chung YG
    Neurosurgery; 2010 Nov; 67(5):1386-95; discussion 1395. PubMed ID: 20871442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
    Li GH; Wei H; Lv SQ; Ji H; Wang DL
    Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
    Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
    J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic therapies in glioblastoma multiforme.
    McNamara MG; Mason WP
    Expert Rev Anticancer Ther; 2012 May; 12(5):643-54. PubMed ID: 22594899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells.
    Ghosh MK; Sharma P; Harbor PC; Rahaman SO; Haque SJ
    Oncogene; 2005 Nov; 24(49):7290-300. PubMed ID: 16007122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
    Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
    J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.